Skip to main content

Estabrook Capital Management

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1344717 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$155,885
-$37,275 QoQ
Shares Held
250
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,067
of 1,322 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Estabrook Capital Management holds $236,684 across 3 Biotechnology names. REGN ranks #1 (65.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
250 $155,885

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $155,885 250
2026-03-31 $193,160 250
2025-12-31 $192,967 250
2025-09-30 $140,567 250
2025-06-30 $131,250 250
2025-03-31 $158,557 250
2024-12-31 $178,082 250
2024-09-30 $262,810 250
2024-06-30 $262,757 250
2024-03-31 $240,622 250
2023-12-31 $219,572 250
2023-09-30 $205,740 250
2023-06-30 $201,191 280
2023-03-31 $230,067 280
2022-12-31 $202,017 280
2022-09-30 $192,883 280
2022-06-30 $165,516 280
2022-03-31 $195,557 280
2021-12-31 $176,825 280
2021-09-30 $151,295 250
2021-06-30 $139,635 250
2021-03-31 $118,285 250
2020-12-31 $120,777 250